GrainCorp Edges Up On Expansion Of Scottish Malting Capacity To Support Distilling Growth

GrainCorp Edges

As a result of strong sectoral growth and customer demand, GrainCorp Ltd (ASX: GNC) has made an announcement today regarding the expansion of its Scottish malting capacity. By upgrading the Arbroath facility, GrainCorp’s United Kingdom-based business, Bairds Malt will result in total annual malting capacity to increase by 79,000 tonnes. It also requires that at their Inverness site, a new state-of-the-art malting plant is built. This will result in increasing the annual capacity of Bairds Malt’s over 300,000 tonnes. Mark Palmquist, the Managing Director and Chief Executive Officer of GrainCorp highlights the history of Bairds Malt of supplying high-quality malt which is one of the primary ingredients of the world’s finest and popular whiskies. The new capacity will help the company to build a strong relationship with the suppliers and be a part of their choice across Scottish distilled industries. The strategical positioning of both the Inverness and Arbroath facilities close to the key customers and good barley supply is a plus point. There has been reported a steady growth in the market for distilling malt in Scotland since 2004 as there is a global demand for aged whisky. As a result of this, it now becomes a long-term focus. Over the past 15 years in Scotland, the total number of distilleries which have increased is 29 in the count. Also, the production capacity of the large distillers has expanded. Keeping the above factors in mind, it can be expected that the company may provide support to the majority of the new capacity before any further construction takes place by entering into either new or extended long-term agreements. In order to fund the expansion, GrainCorp will take support from cash flow and existing debt facilities available across FY19-21. It is expected that the project might complete in calendar year 2021.  

For the half-year period ended 31 March 2018, the company has generated revenue worth A$1,986.8 million. The company made a profit of A$36.1 million. The company has a total asset worth A$ 4,091.8 million. And total liabilities worth A$2,217.7 million. This shows that the company has an ability to meet its long-term obligations. The current asset of the company is A$2024.5 million and total current liabilities are worth A$1,309.8 million. This shows that the company is able to clear its short-term obligations. The total shareholder’s equity is worth A$1,874.1 million. The net cash outflow from the operating activities is A$39.3 million. There was a net cash outflow from the investing activities worth A$57.5 million. The major outflow of cash under investing activities was due to the payments done for the property, plant, and equipment worth A$50.4 million. The net cash outflow from the financing activities was A$0.8 million.

Throughout the journey of the company since listing, the stock performance was 32.7%. The company shows a negative performance of -2.15% in 1 year. During the period of 5 years, the company’s performance was -35.07% and 46.65% in 10 years. For the past 3 months now, the company’s performance is 7.05%. The current market price of the share is A$8.27 (up 0.85% on October 18, 2018) with a market capitalization of A$1.88 billion and PE ratio 26.28x. As per the stock trend, the moving average convergence and divergence line (MACD line) is below the signal line.

Dividend Stocks To Buy

The Income available from dividends remains attractive for many investors.

We take a look at the best yields on the market and assess what they say about a company’s prospect.

Sponsored ad by Kalkine

One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”

ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.

Click here to get your free report.


Disclaimer

The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkinemedia.com and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.


6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report

LEAVE A REPLY

Please enter your comment!
Please enter your name here